Bronchodilator reliever use and its association with the economic and humanistic burden of COPD: a propensity-matched study.

about

Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β-Agonist Therapy: An Integrated Post Hoc Analysis

P2860

Q58760591-EF6D4B20-6042-4FA9-A673-71E299F7C348

P2860

Bronchodilator reliever use and its association with the economic and humanistic burden of COPD: a propensity-matched study.

Item

http://www.wikidata.org/entity/Q39168112

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Bronchodilator reliever use an ...... D: a propensity-matched study.

@en

Bronchodilator reliever use an ...... D: a propensity-matched study.

@nl

type

Item

label

Bronchodilator reliever use an ...... D: a propensity-matched study.

@en

Bronchodilator reliever use an ...... D: a propensity-matched study.

@nl

prefLabel

Bronchodilator reliever use an ...... D: a propensity-matched study.

@en

Bronchodilator reliever use an ...... D: a propensity-matched study.

@nl

P1476

Bronchodilator reliever use an ...... PD: a propensity-matched study

@en

P2093

Ian Naya

http://www.w3.org/2001/XMLSchema#string

Manuel Valle

http://www.w3.org/2001/XMLSchema#string

Mark Small

http://www.w3.org/2001/XMLSchema#string

Robert Wood

http://www.w3.org/2001/XMLSchema#string

Tim Holbrook

http://www.w3.org/2001/XMLSchema#string

Yogesh Suresh Punekar

http://www.w3.org/2001/XMLSchema#string

P2860

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

EuroQol--a new facility for the measurement of health-related quality of life

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

Effects of short-acting bronchodilators added to maintenance tiotropium therapy.

The MRC breathlessness scale.

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.

Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease

Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis.

Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis

P304

28-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13696998.2016.1223085

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hana Müllerová

P577

2016-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27564685

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

Bronchodilator reliever use and its association with the economic and humanistic burden of COPD: a propensity-matched study.

about

P2860

P2860

Bronchodilator reliever use and its association with the economic and humanistic burden of COPD: a propensity-matched study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921